_:n074232e4a455480ebe3da4ba69494a08xb0
<http://schema.org/description>
"The FDA has approved trastuzumab-dkst (Ogivri, Mylan GmbH) as a biosimilar to trastuzumab (Herceptin, Genentech), the first biosimilar for the treatment of certain breast and stomach cancers.\r\n "
<https://www.pharmacytimes.com/view/fda-oks-biosimilar-treatment-for-certain-breast-and-stomach-cancers>